Advertisement

X

GSK’s Combination Meningitis Vaccine Receives FDA Approval

by Kathy Jones on  June 15, 2012 at 10:43 PM Drug News   - G J E 4
A -A +
GlaxoSmithKline has announced that its combination meningitis vaccine, MenHibrix has been approved by the US Food and Drug Administration as a protective vaccination for infants against two bacterial diseases.
 GSK’s Combination Meningitis Vaccine Receives FDA Approval
GSK’s Combination Meningitis Vaccine Receives FDA Approval

MenHibrix is a combination of GSK's meningococcal and Hib vaccines and is administered in a four-dose series at 2, 4, 6 and 12 through 15 months of age. The company said that the vaccine will prevent diseases caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.

Commenting on the approval, GSK Vaccines vice president Leonard Friedland said, "MenHibrix gives healthcare providers the option of combining Hib immunization with meningococcal C and Y immunization without increasing the number of shots for infants and toddlers."

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

Most Popular News on Medindia

P
M
X

Ask an Expert

Ask an Expert+
s
NICE Rejects Vemurafenib for Melanoma Citing Cost...
 NICE Rejects Vemurafenib for Melanoma Citing Costs
S  Speedy Detection Of Flu Virus Using SMART Biochip
Speedy Detection Of Flu Virus Using SMART Biochip